Saturday, March 15, 2025
spot_img

Orion Corporation: Managers’ transactions – Niclas Lindstedt

ORION CORPORATION
MANAGERS’ TRANSACTIONS
11 MARCH 2025 at 09.00 EET
        

Orion Corporation: Managers’ transactions – Niclas Lindstedt

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion Oyj – Managers’ Transactions
____________________________________________
Person subject to the notification requirement
Name: Niclas Lindstedt
Position: Other senior manager
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 99438/5/4

____________________________________________
Transaction date: 2025-03-10
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009014377
Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details
(1): Volume: 6333 Unit price: 0 EUR

Aggregated transactions (1):
Volume: 6333 Volume weighted average price: 0 EUR

Orion Corporation

Liisa Hurme

President and CEO

    Olli Huotari

Executive Vice President,
Corporate Functions

 

                                                 

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orionpharma.com

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion’s net sales in 2024 amounted to EUR 1,542 million and the company had about 3,700 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.

Powered by SlickText.com

Hot this week

zSpace to Attend the 37th Annual Roth Conference

SAN JOSE, Calif., March 14, 2025 (GLOBE...

NAV announcement

Albion Technology & General VCT PLC LEI Code 213800TKJUY376H3KN16NAV...

NAV announcement

Albion Enterprise VCT PLC LEI Code 213800OVSRDHRJBMO720 NAV announcement...

Albion Crown VCT PLC: Half-yearly Financial Report

Albion Crown VCT PLC LEI Number: 213800SYIQPA3L3T1Q6814 March 2025...

Topics

zSpace to Attend the 37th Annual Roth Conference

SAN JOSE, Calif., March 14, 2025 (GLOBE...

NAV announcement

Albion Technology & General VCT PLC LEI Code 213800TKJUY376H3KN16NAV...

NAV announcement

Albion Enterprise VCT PLC LEI Code 213800OVSRDHRJBMO720 NAV announcement...

Albion Crown VCT PLC: Half-yearly Financial Report

Albion Crown VCT PLC LEI Number: 213800SYIQPA3L3T1Q6814 March 2025...

Ascot Announces Closing of the First Tranche of Private Placement

Not for distribution to U.S. news wire services or...

Heartland Express, Inc. Declares Regular Quarterly Dividend

NORTH LIBERTY, Iowa, March 14, 2025 (GLOBE...
spot_img

Related Articles

Popular Categories

spot_img